Ablation should not be first-line therapy for the treatment of atrial fibrillation

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 4, 2007, Pages 673-679

  Haigney, Mark C ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Ablation; Atrial fibrillation; Randomized trial

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; PLACEBO; SOTALOL; WARFARIN;

ARTICLE; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HEART TAMPONADE; HIGH RISK PATIENT; HUMAN; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERICARDIAL EFFUSION; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY ABLATION; RISK BENEFIT ANALYSIS; RISK REDUCTION; STROKE; SURGICAL RISK; THROMBOEMBOLISM; TREATMENT OUTCOME; WOLFF PARKINSON WHITE SYNDROME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 34447299384     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.4.673     Document Type: Article

References (27)

1. Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation 112(8), 1214-1222 (2005).
2. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 114(7), e257-e354 (2006).
3. Padanilam BJ, Prystowsky EN. Should atrial fibrillation ablation be considered first-line therapy for some patients? Should ablation be first-line therapy and for whom? The antagonist position. Circulation 112(8), 1223-1229 (2005).
4. Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356, 1503-1516 (2007).
5. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L; SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med. 356, 1009-1019 (2007).
6. Calkins H. Catheter ablation should not be first-line therapy for atrial fibrillation. Nat. Clin. Pract. Cardiovasc. Med. 4(1), 4-5 (2007).
7. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285, 2864-2870 (2001).
8. Oral A, Chugh M, Ozyadin E et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation for atrial fibrillation. Circulation 114, 759-765 (2006).
9. Sherman DG. Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control. Stroke 38, 615-617 (2007).
10. Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 112(3), 307-313 (2005).
11. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339, 659-666 (1998).
12. Pappone C, Rosanio S, Augello G et al. Mortality, morbidity and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. J. Am. Coll. Cardiol. 42, 185-197 (2003).
13. Fuster V, Ryden LE, Asinger RW et al. Guidelines for the management of patients with atrial fibrillation. Circulation 104(17), 2118-2150 (2001).
14. Alboni P, Botto GL, Baldi N et al. Outpatient treatment of recent-onset atrial fibrillation with the "pili-in-the-pocket" approach. N. Engl. J. Med. 351(23), 2384-2391 (2004).
15. Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111(9), 1100-1105 (2005).
16. Doll N, Borger MA, Fabricius A et al. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J. Thorac. Cardiovasc. Surg. 125(4), 836-842 (2003).
17. Pappone C, Oral H, Santinelli V et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 109(22), 2724-2726 (2004).
18. Dixit S, Marchlinski FE. How to recognize, manage, and prevent complications during atrial fibrillation ablation. Heart Rhythm 4, 108-115 (2007).
19. Lickfett L, Hackenbroch M, Lewalter T et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J. Cardiovasc. Electrophysiol. 17, 1-7 (2006).
20. Pappone C, Augello, G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J. Am. Coll. Cardiol. 48(11), 2340-2347 (2006).
21. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 347(23), 1825-1833 (2002).
22. Corley SD, Epstein AE, DiMarco JP et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109(12), 1509-1513 (2004).
23. Kaufman ES, Zimmermann PA, Wang T et al: Atrial Fibrillation Follow-up Investigation of Rhythm Management investigators. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis. J. Am. Coll. Cardiol. 44(6), 1276-1282 (2004).
24. Steinberg JS, Sadaniantz A, Kron J et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 109(16), 1973-1980 (2004).
25. Ren JF, Marchlinski FE, Callans DJ, Zado ES. Intracardiac Doppler echocardiographic quantification of pulmonary vein flow velocity: an effective technique for monitoring pulmonary vein ostia narrowing during focal atrial fibrillation ablation. J. Cardiovasc. Electrophysiol. 13(11), 1076-1081 (2002).
26. Saad EB, Rossillo A, Saad CP et al. pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation 108(25), 3102-3107 (2003).
27. Bunch TJ, Asirvatham SJ, Friedman PA et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J. Cardiovasc. Electrophysiol. 16(11), 1172-1179 (2005).